IDYA
IDYA
NASDAQ · Biotechnology

Ideaya Biosciences Inc

$32.75
+0.15 (+0.46%)
As of Mar 22, 9:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
223.27M
Net Income
-116,065,057
Gross Margin
Profit Margin
-52.0%
Rev Growth
+62.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.1% 60.1%
Operating Margin -72.8% -65.6% -18.9% -18.0%
Profit Margin -52.0% -49.4% -21.1% -18.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 223.27M 137.36M 384.15M 440.58M
Gross Profit 230.71M 264.60M
Operating Income -162,628,948 -90,049,251 -72,666,854 -79,390,880
Net Income -116,065,057 -64,266,366 -80,984,777 -83,452,264
Gross Margin 60.1% 60.1%
Operating Margin -72.8% -65.6% -18.9% -18.0%
Profit Margin -52.0% -49.4% -21.1% -18.9%
Rev Growth +62.5% +62.5% -7.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 452.34M 383.43M
Total Equity 2.04B 2.12B
D/E Ratio 0.22 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -159,875,122 -93,442,454 -85,173,040 -109,288,960
Free Cash Flow -100,075,430 -111,173,636